Researchers identify gliocidin, a blood-brain barrier-penetrating prodrug, that targets glioblastoma's unique metabolic vulnerability, offering a promising therapeutic strategy and extended survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback